Efficacy and safety of tenofovir disoproxil fumarate (TDF) in hepatitis B virus (HBV) monoinfection: longitudinal analysis of a UK cohort
View ORCID ProfileTingyan Wang, View ORCID ProfileDavid A Smith, View ORCID ProfileCori Campbell, View ORCID ProfileJolynne Mokaya, Oliver Freeman, View ORCID ProfileHizni Salih, View ORCID ProfileAnna L McNaughton, Sarah Cripps, View ORCID ProfileKinga A Várnai, Theresa Noble, View ORCID ProfileKerrie Woods, Jane Collier, Katie Jeffery, View ORCID ProfileJim Davies, View ORCID ProfileEleanor Barnes, View ORCID ProfilePhilippa C Matthews
doi: https://doi.org/10.1101/2020.12.11.20247940
Tingyan Wang
1Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom
2NIHR Oxford Biomedical Research Centre, Big Data Institute, University of Oxford, Oxford, United Kingdom
David A Smith
2NIHR Oxford Biomedical Research Centre, Big Data Institute, University of Oxford, Oxford, United Kingdom
3Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
Cori Campbell
1Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom
2NIHR Oxford Biomedical Research Centre, Big Data Institute, University of Oxford, Oxford, United Kingdom
Jolynne Mokaya
1Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom
Oliver Freeman
2NIHR Oxford Biomedical Research Centre, Big Data Institute, University of Oxford, Oxford, United Kingdom
4Nuffield Department of Population Health, Oxford, United Kingdom
Hizni Salih
2NIHR Oxford Biomedical Research Centre, Big Data Institute, University of Oxford, Oxford, United Kingdom
4Nuffield Department of Population Health, Oxford, United Kingdom
Anna L McNaughton
1Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom
Sarah Cripps
5Pharmacy Department, John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
Kinga A Várnai
2NIHR Oxford Biomedical Research Centre, Big Data Institute, University of Oxford, Oxford, United Kingdom
3Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
Theresa Noble
2NIHR Oxford Biomedical Research Centre, Big Data Institute, University of Oxford, Oxford, United Kingdom
3Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
Kerrie Woods
2NIHR Oxford Biomedical Research Centre, Big Data Institute, University of Oxford, Oxford, United Kingdom
3Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
Jane Collier
6Department of Hepatology, John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
Katie Jeffery
7Department of Infectious Diseases and Microbiology, John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
Jim Davies
2NIHR Oxford Biomedical Research Centre, Big Data Institute, University of Oxford, Oxford, United Kingdom
8Department of Computer Science, University of Oxford, Oxford, United Kingdom
Eleanor Barnes
1Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom
3Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
Philippa C Matthews
1Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom
3Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
7Department of Infectious Diseases and Microbiology, John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
Data Availability
No additional data are available.
Posted December 14, 2020.
Efficacy and safety of tenofovir disoproxil fumarate (TDF) in hepatitis B virus (HBV) monoinfection: longitudinal analysis of a UK cohort
Tingyan Wang, David A Smith, Cori Campbell, Jolynne Mokaya, Oliver Freeman, Hizni Salih, Anna L McNaughton, Sarah Cripps, Kinga A Várnai, Theresa Noble, Kerrie Woods, Jane Collier, Katie Jeffery, Jim Davies, Eleanor Barnes, Philippa C Matthews
medRxiv 2020.12.11.20247940; doi: https://doi.org/10.1101/2020.12.11.20247940
Efficacy and safety of tenofovir disoproxil fumarate (TDF) in hepatitis B virus (HBV) monoinfection: longitudinal analysis of a UK cohort
Tingyan Wang, David A Smith, Cori Campbell, Jolynne Mokaya, Oliver Freeman, Hizni Salih, Anna L McNaughton, Sarah Cripps, Kinga A Várnai, Theresa Noble, Kerrie Woods, Jane Collier, Katie Jeffery, Jim Davies, Eleanor Barnes, Philippa C Matthews
medRxiv 2020.12.11.20247940; doi: https://doi.org/10.1101/2020.12.11.20247940
Subject Area
Subject Areas
- Addiction Medicine (401)
- Allergy and Immunology (712)
- Anesthesia (204)
- Cardiovascular Medicine (2965)
- Dermatology (250)
- Emergency Medicine (444)
- Epidemiology (12782)
- Forensic Medicine (12)
- Gastroenterology (829)
- Genetic and Genomic Medicine (4610)
- Geriatric Medicine (423)
- Health Economics (732)
- Health Informatics (2939)
- Health Policy (1070)
- Hematology (391)
- HIV/AIDS (927)
- Medical Education (429)
- Medical Ethics (116)
- Nephrology (474)
- Neurology (4392)
- Nursing (237)
- Nutrition (646)
- Oncology (2284)
- Ophthalmology (650)
- Orthopedics (258)
- Otolaryngology (326)
- Pain Medicine (279)
- Palliative Medicine (83)
- Pathology (502)
- Pediatrics (1199)
- Primary Care Research (501)
- Public and Global Health (6981)
- Radiology and Imaging (1539)
- Respiratory Medicine (917)
- Rheumatology (443)
- Sports Medicine (385)
- Surgery (491)
- Toxicology (60)
- Transplantation (212)
- Urology (182)